| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/18/2013 | EP2674152A1 Stable liquid oily ready-to-use formulations, preparation thereof and use thereof |
| 12/18/2013 | EP2674149A1 Method for preparing composite granule comprising low-substituted hydroxypropyl cellulose and rapid release preparation |
| 12/18/2013 | EP2673363A2 Treatment of angiogenesis disorders |
| 12/18/2013 | EP2673362A1 B-type plexin antagonists and uses thereof |
| 12/18/2013 | EP2673281A1 Boron containing polybasic bacterial efflux pump inhibitors and therapeutics uses thereof |
| 12/18/2013 | EP2673279A1 5-amino-oxazepine and 5-amino-thiazepane compounds as beta-secretase antagonists and methods of use |
| 12/18/2013 | EP2673278A1 N-[3-(5-amino-3,3a,7,7a-tetrahydro-1h-2,4-dioxa-6-aza-inden-7-yl)-phenyl]-amides as bace1 and/or bace2 inhibitors |
| 12/18/2013 | EP2673277A1 [1, 2, 4]triazolo [4, 3 -b]pyridazine compounds as inhibitors of the c-met tyrosine kinase |
| 12/18/2013 | EP2673271A1 Hepatitis c virus inhibitors |
| 12/18/2013 | EP2673268A1 Method of inhibiting hamartoma tumor cells |
| 12/18/2013 | EP2673266A1 Phenothiazine diaminium salts and their use |
| 12/18/2013 | EP2673263A1 Novel 1-(1-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)urea derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 12/18/2013 | EP2673262A1 Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds |
| 12/18/2013 | EP2673250A2 Stilbene analogs and methods of treating cancer |
| 12/18/2013 | EP2673049A1 Methods of treating macular edema using antiedema therapeutics |
| 12/18/2013 | EP2672981A1 Multiparticulate l-menthol formulations and related methods |
| 12/18/2013 | EP2672978A1 Permeation enhancers for topical formulations |
| 12/18/2013 | EP2672977A1 Antisense oligonucleotides |
| 12/18/2013 | EP2672976A1 Idrabiotaparinux for the treatment of pulmonary embolism and for the secondary prevention of venous thromboembolic events |
| 12/18/2013 | EP2672975A1 Methods for treating pulmonary hypertension |
| 12/18/2013 | EP2672974A1 Hybrid opioid compounds and compositions |
| 12/18/2013 | EP2672973A1 Administration regime for nitrocatechols |
| 12/18/2013 | EP2672972A2 Methods for treating obstructive sleep apnea |
| 12/18/2013 | EP2672971A1 Metabotropic glutamate receptor group i antagonists for treatment of abnormal union of tissue |
| 12/18/2013 | EP2672970A2 Forms of rifaximin and uses thereof |
| 12/18/2013 | EP2672969A1 Combination |
| 12/18/2013 | EP2672968A1 Econazole composition and methods of treatment therewith |
| 12/18/2013 | EP2672967A1 Compounds and methods for kinase modulation, and indications therefor |
| 12/18/2013 | EP2672966A1 Pharmaceutical composition, methods for treating and uses thereof |
| 12/18/2013 | EP2672965A2 Treatment and prevention of cardiovascular disease and thrombosis |
| 12/18/2013 | EP2672964A1 Composition for use in the treatment of menopause problems/disorders and in the treatment of general aging of the organism |
| 12/18/2013 | EP2672963A2 Methods for treatment of melanoma |
| 12/18/2013 | EP2672962A1 Novel antifungal composition |
| 12/18/2013 | EP2672961A1 Effervescent gamma-hydroxybutyric acid granules |
| 12/18/2013 | EP2672960A1 Pharmaceutical composition comprising tadalafil and a cyclodextrin |
| 12/18/2013 | EP2672959A1 Granulated composition comprising tadalafil and a disintegrant |
| 12/18/2013 | EP2672957A1 Novel composition for the treatment of cystic fibrosis |
| 12/18/2013 | EP2672955A1 Storage-stable formulation of paracetamol in aqueous solution |
| 12/18/2013 | EP2672842A1 Galactofructose for the regulatory effect thereof on intestinal transit |
| 12/18/2013 | EP2672833A2 Method for obtaining a lipid-containing composition from microbial biomass |
| 12/18/2013 | EP2672828A1 Antimicrobial composition |
| 12/18/2013 | EP2672827A1 Pesticidal compositions and processes related thereto |
| 12/18/2013 | EP2672823A1 S1p modulating agents |
| 12/18/2013 | EP2672822A1 Methods and compositions for improving cognitive function |
| 12/18/2013 | EP2672821A1 Cathepsin c inhibitors |
| 12/18/2013 | EP2672820A1 Mannoside compounds and methods of use thereof |
| 12/18/2013 | EP2523961B1 2,5,7-substituted oxazolopyrimidine derivatives |
| 12/18/2013 | EP2521726B1 5-oxo-5,8-dihydropyrido[2,3-d]pyrimidine derivatives as camkii kinases inhibitors for the treatment of cardiovascular diseases |
| 12/18/2013 | EP2519527B1 Thieno[2,3-b]pyridinedione activators of ampk and therapeutic uses thereof |
| 12/18/2013 | EP2496576B1 Imidazo[4,5-c]quinoline derivatives as bromodomain inhibitors |
| 12/18/2013 | EP2496557B1 Tetrahydroquinoline derivatives and their pharmaceutical use |
| 12/18/2013 | EP2491034B1 Fused heterocyclic compounds as orexin receptor modulators |
| 12/18/2013 | EP2488521B1 Macrocyclic integrase inhibitors |
| 12/18/2013 | EP2465580B1 Polycyclic carbamoylpyridone derivatives having hiv integrase inhibitory activity |
| 12/18/2013 | EP2459546B1 New bicyclic dioxanes, their preparation and their use as fragrant compounds |
| 12/18/2013 | EP2446882B1 Medicament with improved storage stability containing the active ingredient hydromorphone |
| 12/18/2013 | EP2445868B1 Biphenyl amides useful as p2x3 and/or p2x2/3 receptors modulators |
| 12/18/2013 | EP2440542B1 Substituted benzimidazoles, benzonthiazoles and benzoxazoles |
| 12/18/2013 | EP2440204B1 Nicotinamide compounds useful as kinase modulators |
| 12/18/2013 | EP2438048B1 Polycyclic antagonists of lysophosphatidic acid receptors |
| 12/18/2013 | EP2426109B1 Novel kinase inhibitors |
| 12/18/2013 | EP2417124B1 Serotonin and norepinephrine reuptake inhibitor |
| 12/18/2013 | EP2398793B1 Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators |
| 12/18/2013 | EP2396340B1 Carba-nucleoside analogs for antiviral treatment |
| 12/18/2013 | EP2392574B1 Indolyl pyrrolidines for the treatment of cancer |
| 12/18/2013 | EP2374807B1 An improved process for the isolation of temozolomide |
| 12/18/2013 | EP2335705B1 Use of sphingomyelin for the treatment of influenza |
| 12/18/2013 | EP2331079B1 Pharmaceutical formulation |
| 12/18/2013 | EP2310018B1 Use of nifurtimox for treating giardiasis |
| 12/18/2013 | EP2265263B1 Chewing composition and the use thereof |
| 12/18/2013 | EP2254570B1 Combination comprising paclitaxel for treating ovarian cancer |
| 12/18/2013 | EP2222672B1 3-aminosulfonyl substituted indole derivatives and methods of use thereof |
| 12/18/2013 | EP2215087B1 Xinafoate salt of n4- (2,2-difluoro-4h-benzo [1,4] oxazin-3-one) - 6-yl] - 5-fluoro-n2 - [3-(methylaminocarbonylmethyleneoxy) phenyl] 2,4-pyrimidinediamine |
| 12/18/2013 | EP2203061B1 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 12/18/2013 | EP2187880B1 Compositions and methods for treating macular degeneration |
| 12/18/2013 | EP2183253B1 Thieno-pyridine derivatives as mek inhibitors |
| 12/18/2013 | EP2177527B1 2'-fluoro-4'-substituted nucleosides, the preparation and use |
| 12/18/2013 | EP2174666B1 Medicinal agent for treatment of amyloid beta-induced cerebral circulation or cerebral blood flow disorders |
| 12/18/2013 | EP2170316B1 Improving memory in subjects with mini-mental state examination of 24-26 |
| 12/18/2013 | EP2165715B1 Therapeutic agent for cancer, and method for treatment of cancer |
| 12/18/2013 | EP2152084B1 Method of manufacturing a ruthenium complex |
| 12/18/2013 | EP2150539B1 Pyridazinone derivatives |
| 12/18/2013 | EP2098517B1 Novel phenyl-isoxazol-3-ol derivative |
| 12/18/2013 | EP2073795B1 Abuse resistant drug formulation |
| 12/18/2013 | EP2069295B1 Substituted cyclopentane derivatives as therapeutic agents |
| 12/18/2013 | EP2059519B1 Nitrogen-containing heterocyclic compounds and methods of use thereof |
| 12/18/2013 | EP2020410B1 Pyrido[2,3-d]pyrimidine derivatives, process for their preparation and their therapeutical use |
| 12/18/2013 | EP2020237B1 Ceramide and chemotherapeutic agents for inducing cell death |
| 12/18/2013 | EP2007370B1 Novel composition for tumor growth control |
| 12/18/2013 | EP1999111B1 Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists |
| 12/18/2013 | EP1982710B1 Composition for prevention of recurrence of stroke |
| 12/18/2013 | EP1968585B1 Veterinarian composition for use as fasciolicide in animals |
| 12/18/2013 | EP1948183B1 Compositions for the treatment and prevention of heart disease and methods of using same |
| 12/18/2013 | EP1932541B1 Apoptosis promoter, cell proliferation inhibitor, prophylactic/therapeutic agent for cancer, screening method for the promoter, inhibitor or agent |
| 12/18/2013 | EP1926473B1 Antimicrobial preparations having a content of octenidine dihydrochloride encapsulated in liposomes |
| 12/18/2013 | EP1814527B1 Bilayer tablet comprising telmisartan and amlodipine |
| 12/18/2013 | EP1782800B1 Methods for detecting JAK3 inhibitors |
| 12/18/2013 | EP1664746B1 Antioxidant sensor and method |
| 12/18/2013 | EP1648427B1 Low dose IgM antibody treatment of demyelinating disorders |
| 12/18/2013 | EP1619199B1 Glycolipid derivatives, process for production of the same, intermediates for synthesis thereof, and process for production of the intermediates |